NO883271L - Vevfaktorinhibitor og isolering derav. - Google Patents

Vevfaktorinhibitor og isolering derav.

Info

Publication number
NO883271L
NO883271L NO88883271A NO883271A NO883271L NO 883271 L NO883271 L NO 883271L NO 88883271 A NO88883271 A NO 88883271A NO 883271 A NO883271 A NO 883271A NO 883271 L NO883271 L NO 883271L
Authority
NO
Norway
Prior art keywords
isolation
tissue factor
factor inhibitor
inhibitor
tissue
Prior art date
Application number
NO88883271A
Other languages
English (en)
Other versions
NO174776B (no
NO883271D0 (no
NO174776C (no
Inventor
George John Broze Jr
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22137642&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO883271(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Washington filed Critical Univ Washington
Publication of NO883271D0 publication Critical patent/NO883271D0/no
Publication of NO883271L publication Critical patent/NO883271L/no
Publication of NO174776B publication Critical patent/NO174776B/no
Publication of NO174776C publication Critical patent/NO174776C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
NO883271A 1987-07-23 1988-07-22 Fremgangsmåte for isolering av vevsfaktorinhibitor (TFI) NO174776C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7736687A 1987-07-23 1987-07-23

Publications (4)

Publication Number Publication Date
NO883271D0 NO883271D0 (no) 1988-07-22
NO883271L true NO883271L (no) 1989-01-24
NO174776B NO174776B (no) 1994-03-28
NO174776C NO174776C (no) 1994-07-06

Family

ID=22137642

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883271A NO174776C (no) 1987-07-23 1988-07-22 Fremgangsmåte for isolering av vevsfaktorinhibitor (TFI)

Country Status (14)

Country Link
US (3) US6534276B1 (no)
EP (1) EP0300988A3 (no)
JP (1) JP2781391B2 (no)
KR (1) KR900007261B1 (no)
AU (1) AU604138B2 (no)
BR (1) BR1100464A (no)
CA (1) CA1338122C (no)
DK (1) DK174522B1 (no)
FI (1) FI97298C (no)
IL (1) IL87172A (no)
NO (1) NO174776C (no)
NZ (1) NZ225534A (no)
PT (1) PT88075B (no)
ZA (2) ZA885370B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co cDNA of human tissue factor inhibitor
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
DK0473564T3 (da) * 1990-08-27 1996-04-15 Monsanto Co Antikoagulant kombination af LACI og sulfatiserede polysaccharider
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5346991A (en) * 1991-06-13 1994-09-13 Genentech, Inc. Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
KR100443572B1 (ko) * 2002-05-29 2004-08-09 광양청매실농원영농조합법인 매실 농축액 제조방법
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
CA2488558C (en) 2002-06-07 2013-08-20 Dyax Corp. Prevention and reduction of blood loss
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
PT1981519T (pt) 2005-12-29 2018-02-23 Dyax Corp Inibição de protéases
WO2007092607A2 (en) * 2006-02-09 2007-08-16 Genetech, Inc. Treatment of hemorrhagic viral infections using a tissue factor inhibitor
EP2195010A4 (en) * 2007-08-21 2012-03-14 Genzyme Corp TREATMENT WITH INHIBITORS OF KALLIKREINE
JP5580205B2 (ja) * 2007-11-19 2014-08-27 セレラ コーポレーション 肺癌マーカーとその使用
US8637454B2 (en) 2009-01-06 2014-01-28 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
RS62853B1 (sr) 2010-01-06 2022-02-28 Takeda Pharmaceuticals Co Proteini koji vezuju kalikrein plazme
AU2012204202A1 (en) 2011-01-06 2013-07-11 Dyax Corp. Plasma kallikrein binding proteins
AU2015235967B2 (en) 2014-03-27 2020-10-22 Takeda Pharmaceutical Company Limited Compositions and methods for treatment of diabetic macular edema
CN116077648A (zh) 2015-12-11 2023-05-09 武田药品工业株式会社 血浆激肽释放酶抑制剂及其治疗遗传性血管性水肿发作的用途
MX2022008649A (es) 2020-01-13 2022-09-23 Takeda Pharmaceuticals Co Inhibidores de calicreina plasmatica y sus usos para tratar episodios de angioedema hereditario pediatrico.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE81149B1 (en) * 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
US5223427A (en) * 1987-03-31 1993-06-29 The Scripps Research Institute Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain
EP0321526A1 (en) * 1987-06-12 1989-06-28 Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of human tissue factor
US4966852A (en) * 1987-07-23 1990-10-30 Monsanto Company DNA clone of human tissue factor inhibitor

Also Published As

Publication number Publication date
KR890001581A (ko) 1989-03-27
US20030166194A1 (en) 2003-09-04
IL87172A (en) 1994-12-29
US6806360B2 (en) 2004-10-19
AU1928688A (en) 1989-02-02
EP0300988A3 (en) 1990-04-11
PT88075B (pt) 1995-06-30
DK174522B1 (da) 2003-05-12
NO174776B (no) 1994-03-28
US6534276B1 (en) 2003-03-18
NO883271D0 (no) 1988-07-22
ZA885370B (en) 1989-10-25
EP0300988A2 (en) 1989-01-25
FI883477L (fi) 1989-01-24
ZA885371B (en) 1989-04-26
FI883477A0 (fi) 1988-07-22
DK413588D0 (da) 1988-07-22
CA1338122C (en) 1996-03-05
US7060805B2 (en) 2006-06-13
AU604138B2 (en) 1990-12-06
US20040265981A1 (en) 2004-12-30
FI97298B (fi) 1996-08-15
KR900007261B1 (en) 1990-10-06
JP2781391B2 (ja) 1998-07-30
BR1100464A (pt) 2000-02-08
IL87172A0 (en) 1988-12-30
DK413588A (da) 1989-01-24
NZ225534A (en) 1991-02-26
FI97298C (fi) 1996-11-25
NO174776C (no) 1994-07-06
PT88075A (pt) 1989-07-31
JPS6447799A (en) 1989-02-22

Similar Documents

Publication Publication Date Title
NO883271L (no) Vevfaktorinhibitor og isolering derav.
NO881660D0 (no) Hepariner og femgangsmaate for deres fremstilling.
DK617288D0 (da) Renin-inhibitorer, deres fremstilling og anvendelse
NO175282C (no) Mikrobicid mikroemulsjon og anvendelse derav
NO880193L (no) Vevveksthjelpemiddel og fremstilling derav.
DK543189D0 (da) Lysyloxidaseinhibitorer og deres anvendelse
NO880434L (no) Bedoevelsesmiddel og fremgangsmaate for bruk derav.
DK14988D0 (da) Malariavaccine og dens anvendelse
NO901745L (no) Fremgangsmaate og system for aa gjennomfoere minesveiping.
NO882940D0 (no) Fremgangsmaate for fremstilling av castanosperminestere og glycosider.
NO880186D0 (no) Tetrapeptidinhibitor samt fremgangsmaate for dets fremstilling og anvendelse derav.
NO893892L (no) Antimikrobiologisk sammensetning og fremgangsmaate for anvendelse.
NO870210L (no) Fremgangsmaate og anordning for avskinning.
NO883114D0 (no) 1h-pyrazol-1-alkanamider og fremgangsmaate for deres fremstilling.
NO881713L (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO893474D0 (no) Flammehemmende midler og fremgangsmaate for anvendelse.
NO881902D0 (no) Sopparoma og fremstilling derav.
NO883927D0 (no) Staal og anvendelse av dette.
NO905543D0 (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
NO910084L (no) Haandkle og fremgangsmaate til fremstilling derav.
NO900271D0 (no) Forbindelse og anvendelse.
NO912279D0 (no) Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter.
NO890097D0 (no) Liposom/doksorubicin-sammensetning og fremgangsmaate.
DK296490D0 (da) Praeserveringsmiddel og anvendelse heraf
NO890087D0 (no) Fremgangsmaater og blandinger for aa forhindre mavesaar.

Legal Events

Date Code Title Description
MK1K Patent expired